Trial intelligence / Profile preview

Buprenorphine Maintenance for Opioid Addicts

NCT00000202Phase 2Completed

Sponsor
Yale University
Start
Aug 1988
Primary completion
May 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2 trial of buprenorphine in opioid use disorder (OUD) and cocaine dependence, sponsored by Yale University. Started Aug 1988; status: completed.

02

Drugs

buprenorphine
03

Conditions

opioid use disorder (OUD)cocaine dependence

Beyond the preview

Go deeper on NCT00000202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call